Response to Neoadjuvant Chemotherapy in Breast Cancer Could be Predictable by Measuring a Novel Serum Apoptosis Product, Caspase-Cleaved Cytokeratin 18: A Prospective Pilot Study

Author： Demiray Mutlu   Ulukaya Engin Engin   Arslan Murat   Gokgoz Sehsuvar   Saraydaroglu Ozlem   Ercan Ilker   Evrensel Turkkan   Manavoglu Osman  

Publisher： Informa Healthcare

ISSN： 0735-7907

Source： Cancer Investigation, Vol.24, Iss.7, 2006-09, pp. : 669-676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

DCE-MRI parameters have potential to predict response of locally advanced breast cancer patients to neoadjuvant chemotherapy and hyperthermia: A pilot study

By Craciunescu Oana   Blackwell Kimberly   Jones Ellen   Macfall James   Yu Daohai   Vujaskovic Zeljko   Wong Terence   Liotcheva Vlayka   Rosen Eric   Prosnitz Leonard   Samulski Thaddeus   Dewhirst Mark  

International Journal of Hyperthermia, Vol. 25, Iss. 6, 2009-09 ,pp. : 405-415

Informa Healthcare

Access to resources Recommend Favorite

Reply to “Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on ‘Early Assessment of Axillary Response with 18F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Ann Surg Oncol. 2013;20(7):2227–35’”

By Koolen Bas   Wesseling Jelle  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 700-700

Springer Publishing Company

Access to resources Recommend Favorite

Anti-cytokeratin CAM5.2 Recognized CK8 Mainly, but not CK18: Comment on “Early Assessment of Axillary Response with 18F-FDG PET/CT During Neoadjuvant Chemotherapy in Stage II–III Breast Cancer: Implications for Surgical Management of the Axilla. Annals of Surgical Oncology doi: 10.1245/s10434-013-2902-0 (2013)”

By Chao Wan-Ru   Han Chih-Ping  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 699-699

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of good clinical response to neoadjuvant chemotherapy in primary breast cancer using [ 18 F]-fluorodeoxyglucose positron emission tomography

By Burcombe R.J.   Makris A.   Pittam M.   Lowe J.   Emmott J.   Wong W.L.  

European Journal of Cancer, Vol. 38, Iss. 3, 2002-01 ,pp. : 375-379

Elsevier

Access to resources Recommend Favorite

Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: A prospective study

By Amadori D.  

Breast Cancer Research and Treatment, Vol. 43, Iss. 1, 1997-03 ,pp. : 7-14

Springer Publishing Company

Access to resources Recommend Favorite